---
title: "Stem Cell Therapy for Multiple Sclerosis: What the Research Shows and What to Ask Before You Travel"
description: "An honest guide to mesenchymal stem cell therapy for MS: what the trials found, how it differs from HSCT, our 300M IV + 50M intrathecal protocol, cost, risks, and who may be a candidate."
canonical: "https://dreambody.clinic/stem-cell-therapy-multiple-sclerosis/"
---

# Stem Cell Therapy for Multiple Sclerosis: What the Research Shows and What to Ask Before You Travel

If you live with multiple sclerosis, you’ve probably read more research than most doctors expect. You may have heard about stem cell transplants that seem to stop MS in its tracks, seen clinic videos with dramatic recoveries, and then found studies that say the evidence is mixed. It’s hard to know what to believe.

This guide is our attempt to give you a straight answer. We’ll explain the different kinds of “stem cell therapy” for MS (they aren’t the same thing), what the best trials of mesenchymal stem cells have actually found, exactly what our protocol involves, the risks, and who may be a reasonable candidate. Mesenchymal stem cell therapy for MS is investigational. Some patients report meaningful improvements, some notice little change, and no one can promise you a result.

## First, Two Very Different Treatments Share One Name

When people say “stem cell therapy for MS,” they usually mean one of two things.

**Autologous hematopoietic stem cell transplantation (aHSCT).** This uses your own blood-forming stem cells. You receive chemotherapy to wipe out much of your existing immune system, and then your stored stem cells are returned so a new immune system can grow back. It’s done in hospitals, it carries the serious risks of chemotherapy, and it has the strongest evidence of any stem cell approach in MS. In a randomized trial of 110 people with relapsing-remitting MS who kept relapsing on medication, disease progression occurred in 3 people after aHSCT compared with 34 people who switched to another disease-modifying therapy ([Burt et al., JAMA, 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6439765/)).

**Mesenchymal stem cell (MSC) therapy.** This is what we offer. MSCs are a different cell type. They don’t rebuild your immune system and there’s no chemotherapy. Instead, they’re thought to act mainly through **paracrine signaling**, releasing proteins and other signals that may calm inflammation and influence how immune cells behave. The evidence for MSCs in MS is earlier-stage and more mixed than for aHSCT.

We think it matters that you know this difference. The aHSCT results are sometimes quoted in a way that makes them sound like they apply to every stem cell treatment, and they don’t. If you have very active relapsing MS, aHSCT is worth discussing with an MS neurologist.

## What Do Trials of MSCs in MS Show?

Here’s a fair summary of the larger controlled studies.

**The MESEMS trial (2021).** This was the biggest controlled trial of MSCs in MS so far. It enrolled 144 people with active relapsing or progressive MS across 15 sites in nine countries. Each received an IV infusion of their own bone marrow MSCs and a placebo infusion, in random order. The treatment was safe and well tolerated, with no serious adverse events in the MSC group. But it **did not reduce** new inflammatory MRI lesions at 24 weeks compared with placebo, and the investigators concluded that the study doesn’t support using bone marrow MSCs to treat active MS ([Uccelli et al., Lancet Neurology, 2021](https://doi.org/10.1016/S1474-4422(21)00301-X)).

**Intrathecal vs IV vs sham (2020).** A smaller trial of 48 people with progressive MS compared bone marrow MSCs given into the spinal fluid (intrathecally), MSCs given by IV, and a sham procedure. At six months, disability worsened in 6.7% of the intrathecal group and 9.7% of the IV group, compared with 41.9% of the sham group. The intrathecal route performed better than IV on several measures. The researchers called the benefits short-term and said a larger phase III trial is needed to confirm them ([Petrou et al., Brain, 2020](https://doi.org/10.1093/brain/awaa333)).

**Umbilical cord MSCs (2018).** A 20-person study gave seven IV infusions of umbilical cord tissue MSCs over seven days. No serious side effects were reported, and participants showed improvements in disability scores, walking times and bladder and bowel symptoms, most noticeably at one month. This study had no control group, so it can’t show that the cells caused the changes ([Riordan et al., Journal of Translational Medicine, 2018](https://pmc.ncbi.nlm.nih.gov/articles/PMC5845260/)).

**Fat-derived MSCs (2018).** A small placebo-controlled study in secondary progressive MS was designed mainly to test safety and found the treatment feasible and well tolerated ([Fernández et al., PLoS One, 2018](https://pmc.ncbi.nlm.nih.gov/articles/PMC5955528/)).

**What this adds up to.** MSCs given by IV or intrathecal injection appear generally well tolerated in trials. Signals of benefit exist, especially in one intrathecal study, but they’re inconsistent, studies are small, follow-up is short, and the largest trial was negative on its main measure. We also want to be clear that most of these trials used patients’ own bone marrow or fat cells, while our protocol uses donor cells from Wharton’s jelly and placenta. Results from one cell type and delivery method don’t automatically carry over to another.

## What MSC Therapy Can and Can't Do

Based on that evidence, here’s how we frame it with patients:

- **It isn’t a cure.** MS can relapse or progress after any treatment, including ours.
- **It doesn’t replace your disease-modifying therapy.** Decisions about your MS medication belong with your neurologist.
- **We can’t promise it will stop progression or repair myelin.** Lab and animal research on remyelination is interesting, but trials haven’t shown that MSCs repair myelin in people.
- **Some patients report improvements** in things like fatigue, mobility or day-to-day function. Others notice little or no change. People with MS for many years and significant mobility loss tend to report smaller changes than those treated earlier in their disease.

## Our MS Protocol

Here’s exactly what our [MS treatment](https://dreambody.clinic/multiple-sclerosis-stem-cell-treatment/) includes:

|  |  |
| --- | --- |
| **IV infusion** | 300 million culture-expanded MSCs |
| **Intrathecal injection** | 50 million MSCs delivered into the cerebrospinal fluid |
| **Also included** | An NAD+ and high-dose vitamin C IV drip after the stem cell IV |
| **Cells** | Donor MSCs from Wharton’s jelly (umbilical cord tissue) and placenta from healthy, live births |
| **Pre-treatment** | Bloodwork at the clinic |
| **Price** | $14,500 USD |
| **Minimum stay** | 5 days in Bucerías, near Puerto Vallarta |

Our cells are grown in our own lab in Bucerías, which holds three COFEPRIS licenses (Mexico’s federal health regulator) covering stem cell production, cryobank storage and regenerative medicine practice. Cells are expanded in a GMP-grade, xeno-free medium in a cleanroom, tested by COFEPRIS-authorized third-party labs, and given within 24 hours of leaving culture. You can see the licenses on our [certified stem cells page](https://dreambody.clinic/certified-stem-cells/), and our article on [how our cells are made and tested](https://dreambody.clinic/science-and-quality-of-our-mesenchymal-stem-cells/) explains more.

COFEPRIS licenses our facility and lab. That isn’t the same as approval of MSC therapy for MS, and these treatments are not FDA-approved in the United States.

## Risks and Side Effects

We’d rather you hear about risks from us before you book. From our own experience with this protocol:

- **Fever or headache** for a few hours after the IV, or the next day, in about 1 in 100 patients.
- **Lower back soreness** near the intrathecal injection site in about 1 in 30 patients, usually lasting a few hours to a few days.
- **A migraine-like headache, sometimes with nausea,** after the intrathecal injection in about 1 in 30 patients, usually lasting a few hours to a few days.
- **Infection** is a risk with any injection or IV, including a spinal injection.
- **Clots or vein irritation** are a rare risk with any IV, which is one reason we do bloodwork first.
- **No response.** Some patients notice no change.

**Blood thinners matter for the intrathecal injection.** It can’t be done while you’re taking blood thinners, because your blood needs to clot normally after the needle enters the spinal fluid sac. Our anesthesiologist’s guidance involves being off most blood thinners for a period before and after treatment, and off aspirin for a shorter period. **Never stop a blood thinner on your own.** Talk to the doctor who prescribed it first, because for some people stopping isn’t safe, and in that case intrathecal treatment may not be right for you.

The U.S. FDA has warned consumers about unapproved stem cell products and reports of serious harms elsewhere. That’s part of why we publish our protocol, licenses and testing, and why we review every case before booking.

## Who May Be a Candidate?

A physician reviews every case before you book anything. In general, people who may be reasonable candidates:

- Have a confirmed MS diagnosis from a neurologist, with recent MRI reports and records
- Understand the treatment is investigational and may not help
- Are willing to keep their own neurologist involved and not change their MS medication without them
- Are medically stable enough to travel and to have a spinal injection

You may not be a good candidate if:

- You’ve had cancer in the past five years (we don’t treat these patients)
- You can’t safely pause blood thinners
- You’re in the middle of a relapse or recently started a new therapy
- You’re a strong candidate for aHSCT and haven’t yet discussed it with an MS specialist

If we don’t think treatment is likely to be worthwhile for you, we’ll tell you.

## Your 5-Day Trip

| Day | What happens |
| --- | --- |
| **Day 1** | Arrive in Puerto Vallarta and rest |
| **Day 2** | Bloodwork, then payment |
| **Day 3** | Treatment: the IV infusion and the intrathecal injection |
| **Day 4** | Rest |
| **Day 5** | Fly home |

Exact days can shift with scheduling. If MS fatigue or mobility makes travel harder, tell us early so we can plan accessible transport and rest time. Our [travel guide](https://dreambody.clinic/travel-guide-stem-cell-treatment-bucerias/) and [hotel options](https://dreambody.clinic/hotels/) can help you plan.

## After Treatment

We follow up remotely at 3, 6 and 12 months. Patients who respond often report changes over the first few months, but timelines vary. Keep seeing your neurologist and keep your usual MRI schedule, so changes are tracked by the same team that knows your history. If you notice no change by six months, tell us honestly so we can talk through what that means.

**Seek urgent care right away** if you develop a fever with a stiff neck, a severe headache that doesn’t ease when you lie down, new weakness or numbness, or loss of bladder or bowel control after your intrathecal injection.

## Questions to Ask Any Clinic

Whether you choose us, a center in Panama or a hospital aHSCT program, ask:

1. Is this MSC therapy or aHSCT, and what published trial evidence supports it?
2. What cell type and dose will I get, and by what route?
3. Who performs the intrathecal injection, and how are complications handled?
4. Will you coordinate with my neurologist?
5. What does the price include, and what’s extra?
6. What happens if I don’t respond?

Our guides on [Mexico vs Panama](https://dreambody.clinic/mexico-vs-panama-stem-cell-therapy/) and [how to choose a stem cell clinic](https://dreambody.clinic/how-to-choose-a-stem-cell-clinic/) go deeper.

## Frequently Asked Questions

**Is stem cell therapy a cure for MS?** No. MSC therapy is investigational. Some patients report improvements, but MS can still relapse or progress, and no treatment we offer is a cure.

**Can MSCs repair myelin?** Lab and animal studies suggest MSCs may support the environment for repair, but human trials haven’t shown that they rebuild myelin. We don’t promise structural repair.

**Do I need to stop my MS medication?** Don’t stop or change any MS medication without your neurologist. Share your full medication list with us, and our physician will review it with you.

**Why intrathecal as well as IV?** The intrathecal injection places cells in the spinal fluid rather than the bloodstream. In one small trial, intrathecal MSCs performed better than IV on several measures, but this hasn’t been confirmed in larger trials.

**Can people with progressive MS be treated?** We review progressive cases individually. Much of the MSC research includes progressive MS, but benefits have been modest and short-term in trials.

**How much does it cost?** Our MS protocol is $14,500 USD, including the 300 million MSC IV, the 50 million MSC intrathecal injection, and an NAD+ and vitamin C IV. Flights and hotel are separate.

**Is MSC therapy the same as HSCT?** No. HSCT uses chemotherapy and your own blood stem cells to rebuild the immune system and has stronger evidence. MSC therapy uses donor cells without chemotherapy and is earlier-stage.

## Thinking About Your Options?

If you’re weighing whether MSC therapy makes sense for your MS, a free consultation is a good place to start. It’s a conversation, not a commitment. A physician will review your records and MRIs, explain what the evidence does and doesn’t show for your type of MS, and tell you honestly whether we think treatment is a reasonable option.

**[Schedule your free consultation](https://dreambody.clinic/contact/)**, call (888) 704-3977, WhatsApp +52 322 232 1055, or email info@dreambodyclinic.net.

---

*Disclaimer: This article is for educational purposes and is not medical advice. Mesenchymal stem cell therapy for multiple sclerosis is investigational and is not approved by the U.S. FDA. Published evidence is limited and mixed, results vary, and some patients see little or no benefit. Treatment is provided in Mexico at a COFEPRIS-licensed facility. Do not stop or change any MS or blood-thinning medication without your own doctor. Please consult your physician before making treatment decisions.*
